Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Oxycodone × Genitourinary × Clear all

Phase

Phase 4 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Tumor-Agnostic 1 Thoracic 1 Other 1 Genitourinary 1 Breast 1

Conditions

Prostatic Neoplasms 1 Cancer Pain 1

Interventions

enzalutamide 10 Zoledronic Acid 10 Leuprolide 8 bicalutamide 6 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6 luprolide acetate gel depot 5 Sunitinib 5 Prednisone 5 Nivolumab 5 Magnetic Resonance Spectroscopy 5 Everolimus 5 Abiraterone Acetate 5 Triptorelin Pamoate 4 Propofol 4 Goserelin 4 Dutasteride 4 Androgen Antagonists 4 pazopanib 3 darolutamide 3 Specimen Handling 3 Sodium Chloride 3 Prednisolone 3 Flutamide 3 Fentanyl 3 5-aminolevulinic acid hexyl ester 3 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3 olaparib 2 fluciclovine F-18 2 enfortumab vedotin 2 disitamab vedotin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07001709 2025-06-03

ENABLE

Deventer Ziekenhuis

Phase 4 Recruiting

Cancer Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡